Aims The aim of this study was to assess concordance between the indocyanine green (ICG) method and 99mTc-radiotracer method to identify the sentinel node (SN) in breast cancer. Evidence supports the feasibility and efficacy of the ICG to identify the SN, however this method has not been prospectively compared with the gold-standard radiotracer method in terms of SN detection rate. Methods Between June 2011 and January 2013, 134 women with clinically node-negative early breast cancer received subdermal/peritumoral injection of 99mTc-labeled tracer for lymphoscintigraphy, followed by intraoperative injection of ICG for fluorescence detection of SNs using an exciting light source combined with a camera. In all patients, SNs were first identified by the fluorescence method (ICG-positive) and removed. A gamma ray-detecting probe was then used to determine whether ICG-positive SNs were hot (99mTc-positive) and to identify and remove any 99mTc-positive (ICG-negative) SNs remaining in the axilla. The study was powered to perform an equivalence analysis. Results The 134 patients provided 246 SNs, detected by one or both methods. 1, 2 and 3 SNs, respectively, were detected, removed and examined in 70 (52.2%), 39 (29.1%) and 17 (12.7%) patients; 4-10 SNs were detected and examined in the remaining 8 patients. The two methods were concordant for 230/246 (93.5%) SNs and discordant for 16 (6.5%) SNs. The ICG method detected 99.6% of all SNs. Conclusions Fluorescent lymphangiography with ICG allows easy identification of axillary SNs, at a frequency not inferior to that of radiotracer, and can be used alone to reliably identify SNs.

The indocyanine green method is equivalent to the 99mTc-labeled radiotracer method for identifying the sentinel node in breast cancer : a concordance and validation study / B. Ballardini, L. Santoro, C. Sangalli, O. Gentilini, G. Renne, G. Lissidini, G.M. Pagani, A. Toesca, C. Blundo, A. Del Castillo, N. Peradze, P. Caldarella, P. Veronesi. - In: EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. - ISSN 0748-7983. - 39:12(2013), pp. 1332-1336. [10.1016/j.ejso.2013.10.004]

The indocyanine green method is equivalent to the 99mTc-labeled radiotracer method for identifying the sentinel node in breast cancer : a concordance and validation study

C. Blundo;N. Peradze;P. Veronesi
2013

Abstract

Aims The aim of this study was to assess concordance between the indocyanine green (ICG) method and 99mTc-radiotracer method to identify the sentinel node (SN) in breast cancer. Evidence supports the feasibility and efficacy of the ICG to identify the SN, however this method has not been prospectively compared with the gold-standard radiotracer method in terms of SN detection rate. Methods Between June 2011 and January 2013, 134 women with clinically node-negative early breast cancer received subdermal/peritumoral injection of 99mTc-labeled tracer for lymphoscintigraphy, followed by intraoperative injection of ICG for fluorescence detection of SNs using an exciting light source combined with a camera. In all patients, SNs were first identified by the fluorescence method (ICG-positive) and removed. A gamma ray-detecting probe was then used to determine whether ICG-positive SNs were hot (99mTc-positive) and to identify and remove any 99mTc-positive (ICG-negative) SNs remaining in the axilla. The study was powered to perform an equivalence analysis. Results The 134 patients provided 246 SNs, detected by one or both methods. 1, 2 and 3 SNs, respectively, were detected, removed and examined in 70 (52.2%), 39 (29.1%) and 17 (12.7%) patients; 4-10 SNs were detected and examined in the remaining 8 patients. The two methods were concordant for 230/246 (93.5%) SNs and discordant for 16 (6.5%) SNs. The ICG method detected 99.6% of all SNs. Conclusions Fluorescent lymphangiography with ICG allows easy identification of axillary SNs, at a frequency not inferior to that of radiotracer, and can be used alone to reliably identify SNs.
Breast cancer sentinel node biopsy; Indocyanine green; Radio-labeled colloid; Sentinel node identification; Surgery; Oncology
Settore MED/18 - Chirurgia Generale
Article (author)
File in questo prodotto:
File Dimensione Formato  
main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 174.38 kB
Formato Adobe PDF
174.38 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/624893
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 77
  • ???jsp.display-item.citation.isi??? 68
social impact